Moreover, considering the importance of the aforementioned signaling paths and the therapeutic potential of EcN in GI disorders, we followed the controlling impact(s) of EcN on the initiation and progression of colorectal cancer throughout the investigation of AKT, PTEN, Bax, and Bcl-xL expressions. The gene discussed is AKT1; the disease is colorectal cancer.